Nanoviricides Inc (NNVC)
2.07
-0.16
(-7.17%)
USD |
NYAM |
May 17, 16:00
2.08
+0.01
(+0.48%)
After-Hours: 20:00
Nanoviricides Cash from Operations (Quarterly): -1.719M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.719M |
| September 30, 2023 | -1.172M |
| June 30, 2023 | -1.499M |
| March 31, 2023 | -1.738M |
| December 31, 2022 | -1.400M |
| September 30, 2022 | -1.033M |
| June 30, 2022 | -1.398M |
| March 31, 2022 | -1.655M |
| December 31, 2021 | -2.114M |
| September 30, 2021 | -0.7242M |
| June 30, 2021 | -2.228M |
| March 31, 2021 | -1.435M |
| December 31, 2020 | -2.315M |
| September 30, 2020 | -2.236M |
| June 30, 2020 | -1.708M |
| March 31, 2020 | -2.397M |
| December 31, 2019 | -1.126M |
| September 30, 2019 | -1.434M |
| June 30, 2019 | -1.672M |
| March 31, 2019 | -2.010M |
| December 31, 2018 | -2.158M |
| September 30, 2018 | -0.9622M |
| June 30, 2018 | -3.519M |
| March 31, 2018 | -1.296M |
| December 31, 2017 | -1.404M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.557M |
| June 30, 2017 | -1.009M |
| March 31, 2017 | -2.052M |
| December 31, 2016 | -2.611M |
| September 30, 2016 | -2.225M |
| June 30, 2016 | -1.382M |
| March 31, 2016 | -2.580M |
| December 31, 2015 | -1.213M |
| September 30, 2015 | -1.654M |
| June 30, 2015 | -1.256M |
| March 31, 2015 | -2.088M |
| December 31, 2014 | -1.172M |
| September 30, 2014 | -1.696M |
| June 30, 2014 | -0.9556M |
| March 31, 2014 | -1.861M |
| December 31, 2013 | -2.193M |
| September 30, 2013 | -1.324M |
| June 30, 2013 | -1.372M |
| March 31, 2013 | -1.708M |
| December 31, 2012 | -1.372M |
| September 30, 2012 | -1.345M |
| June 30, 2012 | -0.8965M |
| March 31, 2012 | -1.419M |
| December 31, 2011 | -1.226M |
| September 30, 2011 | -0.6763M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.397M
Minimum
Mar 2020
-0.7242M
Maximum
Sep 2021
-1.632M
Average
-1.655M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | -31.17M |
| Enanta Pharmaceuticals Inc | -28.60M |
| GlycoMimetics Inc | -10.51M |
| FibroGen Inc | -59.29M |
| Corvus Pharmaceuticals Inc | -5.157M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0055M |
| Free Cash Flow | -6.203M |
| Free Cash Flow Per Share (Quarterly) | -0.1468 |
| Free Cash Flow Yield | -25.63% |